Search results
If You Invested $25,000 in Biogen in 2018, This Is How Much You Would Have Today
Motley Fool· 1 year agoFive years ago, pharmaceutical manufacturer Biogen (NASDAQ: BIIB) had a growing business, and...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Why Is Biogen Inc. (BIIB) Up 8.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent
Benzinga via Yahoo Finance· 2 years agoThe U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen...
Biogen Is Suffering From Doubts About the Future
GuruFocus.com via Yahoo Finance· 1 month agoBiogen Inc. (NASDAQ:BIIB) is an American biopharmaceutical company specializing in the development and commercialization of biosimilars and medicines...
Biogen (BIIB) to Report Q3 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 years agoBiogen BIIB will report third-quarter 2022 results on Oct 25, before market open. In the last...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 3 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 3 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Biogen Skids On 'Low-Quality' Beat, Cuts Profit Guidance Following Reata Buyout
Investor's Business Daily· 6 months agoBiogen stock skidded Wednesday on a "low-quality" sales beat that relied on other revenue. But...
